secwatch.observer — SEC 8-K summary
======================================

Issuer:     Endo LP (—)
CIK:        0002008861
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001104659-25-073018
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mallinckrodt closes acquisition of Endo; Endo shares converted to 0.2575 MNK shares + $1.31 cash
--------------------------------------------------------------------------------

- Endo shareholders received 0.2575 Mallinckrodt ordinary shares and about $1.31 cash per share, with cash for fractional shares.
- Endo common stock delisted from OTCQX; Form 15 to be filed to suspend SEC reporting obligations.
- All prior directors (Herendeen, Efron, Hirsch, Langlois, Pasternak, Yoskowitz) removed; Matthew Peters and Mark Tyndall appointed sole directors.
- Ex-CEO Scott Hirsch to serve as senior advisor for 60 days, then consultant for 6 months, receiving $750,000/month for 12 months ($9M total).
- Endo converted into Endo LP on August 1, 2025; board approved $645,000 incremental payment to directors for equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2008861/000110465925073018/0001104659-25-073018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2008861/000110465925073018/tm2522236d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-073018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer